{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:49:31Z","timestamp":1792684171565,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac valve calcification (CVC) is common in end-stage renal disease (ESRD). We investigated the effect of CVC on all-cause and cardiovascular (CV) mortality in maintenance hemodialysis (MHD) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted on 434 hemodialysis patients who underwent echocardiography for qualitative assessment of valve calcification with complete follow-up data from January 1, 2014, to April 30, 2021. The baseline data between the CVC and non-CVC groups were compared. The Kaplan\u2013Meier method was used to analyse all-cause and cardiovascular mortality. The association of CVC with all-cause and cardiovascular mortality was evaluated using multivariate Cox regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 27.2% of patients had mitral valve calcification (MVC), and 31.8% had aortic valve calcification (AVC) on echocardiography. Patients with CVC showed significantly higher all-cause (log-rank\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and cardiovascular (log-rank\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) mortality rates than patients without CVC. In multivariate regression analyses, MVC (HR: 1.517,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.010) and AVC (HR: 1.433,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.028) were significant factors associated with all-cause mortality. MVC (HR: 2.340,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and AVC (HR: 2.410,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) were also significant factors associated with cardiovascular mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MVC and AVC increased the risk of all-cause and cardiovascular mortality in MHD patients. Regular follow-up with echocardiography could be a useful method for risk stratification in MHD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-022-02670-5","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T03:02:40Z","timestamp":1642820560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cardiac valve calcification is associated with mortality in hemodialysis patients: a retrospective cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiuxu","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiming","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,22]]},"reference":[{"issue":"13","key":"2670_CR1","first-page":"177","volume":"41","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, Mcculloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;41(13):177.","journal-title":"N Engl J Med"},{"key":"2670_CR2","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1681\/ASN.V92267","volume":"9","author":"R Foley","year":"1998","unstructured":"Foley R. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9:S16\u201323.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2670_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.ajkd.2012.09.007","volume":"61","author":"H Takahashi","year":"2013","unstructured":"Takahashi H, Ishii H, Aoyama T, Kamoi D, Kasuga H, Ito Y, et al. Association of Cardiac Valvular Calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study. Am J Kidney Dis. 2013;61(2):254\u201361.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2670_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12872-018-0747-y","volume":"18","author":"Z Wang","year":"2018","unstructured":"Wang Z, Jiang A, Wei F, Chen H. Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis. BMC Cardiovasc Disord. 2018;18(1):12.","journal-title":"BMC Cardiovasc Disord"},{"key":"2670_CR5","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes CKDMBDWG","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes CKDMBDWG. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney Disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1\u2013130.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"2670_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes CKDMBDUWG","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes CKDMBDUWG. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney Disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1\u201359.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"2670_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/01.ASN.0000038685.95946.83","volume":"14","author":"AY Wang","year":"2003","unstructured":"Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003;14(1):159\u201368.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2670_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1378\/chest.74.1.59","volume":"74","author":"MA Quinones","year":"1978","unstructured":"Quinones MA, Pickering E, Alexander JK. Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining ejection fraction and stroke volume. Chest. 1978;74(1):59\u201365.","journal-title":"Chest"},{"key":"2670_CR9","doi-asserted-by":"crossref","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79\u2013108.","DOI":"10.1016\/j.euje.2005.12.014"},{"key":"2670_CR10","first-page":"327","volume":"12","author":"PH Stevenson","year":"1937","unstructured":"Stevenson PH. Height.weight.surface formula for the estimation of surface area in Chinese subjects. Chin J Phys. 1937;12:327\u201330.","journal-title":"Chin J Phys"},{"key":"2670_CR11","doi-asserted-by":"crossref","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Boehm M, Christiaens T, Cifkova R, Backer GD, Dominiczak A. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281\u2013357.","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"2670_CR12","doi-asserted-by":"publisher","first-page":"S00029149183163","DOI":"10.1016\/j.amjcard.2018.08.009","volume":"122","author":"L Hensen","year":"2018","unstructured":"Hensen L, El MM, Van R, Smit JM, Wouter JJ, Bax JJ, et al. Prevalence and prognostic implications of mitral and aortic valve calcium in patients with chronic kidney Disease. Am J Cardiol. 2018;122:S0002914918316394.","journal-title":"Am J Cardiol"},{"key":"2670_CR13","unstructured":"Group KDIGOC-MW. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1\u2013130."},{"issue":"8","key":"2670_CR14","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.2215\/CJN.01140211","volume":"6","author":"P Raggi","year":"2011","unstructured":"Raggi P, Bellasi A, Gamboa C, Ferramosca E, Ratti C, Block GA, et al. All-cause mortality in hemodialysis patients with heart valve calcification. Clin J Am Soc Nephrol. 2011;6(8):1990\u20135.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2670_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s11255-020-02448-4","volume":"52","author":"M Li","year":"2020","unstructured":"Li M, Ye ZC, Li CM, Zhao WB, Lou TQ. The influence of cardiac valvular calcification on all-cause and cardiovascular mortality in maintenance hemodialysis patients. Int Urol Nephrol. 2020;52(6):943\u201351.","journal-title":"Int Urol Nephrol"},{"key":"2670_CR16","doi-asserted-by":"crossref","unstructured":"Fox, CS, Vasan RS, Parise H, Levy D, O'Donnell CJ, D'Agostino RB, Benjamin EJ, Framingham Heart Study: Mitral Annular Calcification Predicts Cardiovascular Morbidity and Mortality: the Framingham Heart Study. Circulation. 2003;107(11):1492\u20136.","DOI":"10.1161\/01.CIR.0000058168.26163.BC"},{"issue":"3","key":"2670_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJM199907153410302","volume":"341","author":"CM Otto","year":"1999","unstructured":"Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341(3):142\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"2670_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1542-4758.2012.00700.x","volume":"16","author":"L Sha","year":"2012","unstructured":"Sha L, Zhang DL, Wang G, Cui WY, Liu WH. Left ventricular mass index and aortic arch calcification score are independent mortality predictors of maintenance hemodialysis patients. Hemodial Int. 2012;16(4):504\u201311.","journal-title":"Hemodial Int"},{"issue":"4","key":"2670_CR19","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","volume":"65","author":"C Zoccali","year":"2004","unstructured":"Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Malatino LS. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int. 2004;65(4):1492\u20138.","journal-title":"Kidney Int"},{"issue":"4","key":"2670_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/0886022X.2015.1007821","volume":"37","author":"M Stosovic","year":"2015","unstructured":"Stosovic M, Petrovic MZ, Vujisic-Tesic BD, Stanojevic ML, Naumovic RT. Predictive value of echocardiography and its relation to Kt\/V and anthropometric parameters in hemodialysis patients. Ren Fail. 2015;37(4):1\u20138.","journal-title":"Ren Fail"},{"issue":"12","key":"2670_CR21","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.2215\/CJN.04300413","volume":"8","author":"A Kainz","year":"2013","unstructured":"Kainz A, Goliasch G, Wiesbauer F, Binder T, Maurer G, Nesser HJ, et al. Left atrial diameter and survival among renal allograft recipients. Clin J Am Soc Nephrol. 2013;8(12):2100\u20135.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"2670_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/echo.12232","volume":"30","author":"CY Karabay","year":"2013","unstructured":"Karabay CY, Akgun T. The impact of mitral stenosis on left atrial function assessed by two-dimensional speckle tracking echocardiography. Echocardiography. 2013;30(7):863.","journal-title":"Echocardiography"},{"issue":"1","key":"2670_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijcard.2004.01.018","volume":"99","author":"A Trikas","year":"2005","unstructured":"Trikas A, Papathanasiou S, Tousoulis D, Tentolouris K, Vasiliadou K, Antoniades C, et al. Left atrial function, cytokines and soluble apoptotic markers in mitral stenosis: effects of valvular replacement. Int J Cardiol. 2005;99(1):111\u20135.","journal-title":"Int J Cardiol"},{"issue":"4","key":"2670_CR24","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1681\/ASN.2006080881","volume":"18","author":"G Tripepi","year":"2007","unstructured":"Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol. 2007;18(4):1316\u201322.","journal-title":"J Am Soc Nephrol"},{"issue":"43","key":"2670_CR25","doi-asserted-by":"publisher","first-page":"16810","DOI":"10.1073\/pnas.0611202104","volume":"104","author":"N Bodyak","year":"2007","unstructured":"Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A. 2007;104(43):16810\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2670_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/cvr\/cvr133","volume":"91","author":"S Bae","year":"2011","unstructured":"Bae S, Yalamarti B, Ke Q, Choudhury S, Yu H, Karumanchi SA, et al. Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. Cardiovasc Res. 2011;91(4):632\u20139.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"2670_CR27","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5001514","volume":"70","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70(4):771\u201380.","journal-title":"Kidney Int"},{"issue":"4","key":"2670_CR28","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1681\/ASN.2004070573","volume":"16","author":"M Teng","year":"2005","unstructured":"Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol. 2005;16(4):1115\u201325.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2670_CR29","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. Jama. 2012;307(7):674\u201384.","journal-title":"Jama"},{"issue":"1","key":"2670_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1681\/ASN.2013010103","volume":"25","author":"AY Wang","year":"2014","unstructured":"Wang AY, Fang F, Chan J, Wen YY, Qing S, Chan IH, et al. Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial. J Am Soc Nephrol. 2014;25(1):175\u201386.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2670_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/ndt\/gfg513","volume":"19","author":"T Shoji","year":"2004","unstructured":"Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, et al. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant. 2004;19(1):179\u201384.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02670-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02670-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02670-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T03:06:11Z","timestamp":1642820771000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02670-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,22]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2670"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02670-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,22]]},"assertion":[{"value":"25 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research has been approved by the Ethics Committee of General Hospital of Northern Theater Command. Informed consent was waived by the Ethics Committee of General Hospital of Northern Theater Command due to the retrospective nature of the study. All methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}